VIRTUAL: Clinical Trial Update: AAV2-BDNF Gene Therapy in Alzheimer’s Disease

Time: 9:15 am
day: Day One


  • Showcasing how BDNF prevents neuronal death, stimulates neuronal function, and builds new synapses in animal models of Alzheimer’s disease
  • Highlighting the AAV2-BDNF gene therapy as the only potential therapy for Alzheimer’s disease that might improve memory by building new synapses
  • Evaluating the administration of AAV2-BDNF under MRI guidance to humans